Anti P4HA1 pAb (ATL-HPA007599 w/enhanced validation)
Atlas Antibodies
- Catalog No.:
- ATL-HPA007599-25
- Shipping:
- Calculated at Checkout
$423.00
Gene Name: P4HA1
Alternative Gene Name: C-P4Halpha(I), P4HA
Isotype: IgG
Interspecies mouse/rat: ENSMUSG00000019916: 97%, ENSRNOG00000050655: 97%
Entrez Gene ID: 5033
Uniprot ID: P13674
Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Storage Temperature: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
| Product Specifications | |
| Application | WB, ICC, IHC |
| Reactivity | Human |
| Clonality | Polyclonal |
| Host | Rabbit |
| Immunogen | FTSIGQMTDLIHTEKDLVTSLKDYIKAEEDKLEQIKKWAEKLDRLTSTATKDPEGFVGHPVNAFKLMKRLNTEWSELENLVLKDMSDGFISNLTIQRQYFPNDEDQVGAAKALLRLQDTYNLDTDTISKGNLPGVKHKSFLTAEDC |
| Gene Sequence | FTSIGQMTDLIHTEKDLVTSLKDYIKAEEDKLEQIKKWAEKLDRLTSTATKDPEGFVGHPVNAFKLMKRLNTEWSELENLVLKDMSDGFISNLTIQRQYFPNDEDQVGAAKALLRLQDTYNLDTDTISKGNLPGVKHKSFLTAEDC |
| Gene ID - Mouse | ENSMUSG00000019916 |
| Gene ID - Rat | ENSRNOG00000050655 |
| Buffer | 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. |
| Documents & Links for Anti P4HA1 pAb (ATL-HPA007599 w/enhanced validation) | |
| Datasheet | Anti P4HA1 pAb (ATL-HPA007599 w/enhanced validation) Datasheet (External Link) |
| Vendor Page | Anti P4HA1 pAb (ATL-HPA007599 w/enhanced validation) at Atlas Antibodies |
| Documents & Links for Anti P4HA1 pAb (ATL-HPA007599 w/enhanced validation) | |
| Datasheet | Anti P4HA1 pAb (ATL-HPA007599 w/enhanced validation) Datasheet (External Link) |
| Vendor Page | Anti P4HA1 pAb (ATL-HPA007599 w/enhanced validation) |
| Citations for Anti P4HA1 pAb (ATL-HPA007599 w/enhanced validation) – 1 Found |
| Eriksson, Johanna; Le Joncour, Vadim; Jahkola, Tiina; Juteau, Susanna; Laakkonen, Pirjo; Saksela, Olli; Hölttä, Erkki. Prolyl 4-hydroxylase subunit alpha 1 (P4HA1) is a biomarker of poor prognosis in primary melanomas, and its depletion inhibits melanoma cell invasion and disrupts tumor blood vessel walls. Molecular Oncology. 2020;14(4):742-762. PubMed |